Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer [Phase 3]
Phase 3 trial investigating nimotuzumab with gemcitabine in K-RAS wild-type locally advanced or metastatic pancreatic cancer completed with …
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer [Phase 2, Phase 3]
Clinical trial update for GB201 in combination with weekly paclitaxel and low-dose gemcitabine in metastatic pancreatic cancer is currently …
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer [Phase 3]
A Phase 3 randomized trial evaluating camrelizumab with paclitaxel albumin-bound and gemcitabine as first-line therapy for metastatic pancre…
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC [Phase 1]
Phase 1 dose-escalation study of MORAb-066 targeting tissue factor-expressing malignancies, including breast, pancreatic, colorectal, and no…
-
CLINICAL_TRIALS trial_result · 2024-03-28Clinical Trial Update: A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy [Phase 3]
Phase 3 trial of maintenance Fluzoparib in gBRCA/PALB2-mutated metastatic pancreatic cancer terminated after first-line platinum therapy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-18Clinical Trial Update: ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study [Phase 1, Phase 2]
A completed phase 1/2 clinical trial evaluating ABTL0812 in combination with FOLFIRINOX as first-line treatment for metastatic pancreatic ca…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer [EARLY_Phase 1]
Early-phase pilot study investigating perioperative nivolumab and paricalcitol to modulate the tumor microenvironment in resectable pancreat…
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Paricalcitol Trial: Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic Cancer [Phase 2]
Phase II open-label trial evaluating paricalcitol in combination with gemcitabine/nab-paclitaxel for advanced pancreatic cancer has complete…
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma [Phase 2]
This Phase 2 trial evaluating NIR178 in combination with PDR001 across multiple solid tumors and non-Hodgkin lymphoma was terminated, with r…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal Metastases [Phase 2]
Phase 2 clinical trial evaluating combined Nab-paclitaxel pressurized intraperitoneal aerosol chemotherapy with systemic Nab-paclitaxel-gemc…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer [Phase 1, Phase 2]
A combined AL2846 capsule with Gemzar (gemcitabine) was studied in Phase 1/2 for advanced pancreatic cancer; the trial is completed.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating plerixafor in combination with cemiplimab for metastatic pancreatic cancer has completed with results post…
-
CLINICAL_TRIALS trial_result · 2024-02-15Clinical Trial Update: A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations [Phase 2]
A Phase 2 clinical trial update shows results for trastuzumab deruxtecan (Enhertu) in solid tumors with HER2 activating mutations; the study…
-
CLINICAL_TRIALS trial_result · 2024-02-14Clinical Trial Update: Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates [Phase 2]
A Phase 2 clinical trial evaluating perioperative therapy for resectable and borderline-resectable pancreatic adenocarcinoma with molecular …
-
FDA approval · 2024-02-13FDA Approved: ONIVYDE — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)
The FDA approved a supplemental application for ONIVYDE (irinotecan hydrochloride) by Ipsen Biopharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update comparing two chemotherapy regimens in metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Binimetinib and Encorafenib for the Treatment of Pancreatic Cancer in Patients With a Somatic BRAF V600E Mutation [Phase 2]
A phase 2 trial evaluating binimetinib and encorafenib for pancreatic cancer with BRAF V600E mutation was terminated; results have been post…
-
CLINICAL_TRIALS trial_result · 2024-01-22Clinical Trial Update: HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer [Phase 3]
Phase 3 trial update comparing HR070803 with oxaliplatin + 5-FU/LV versus GX as adjuvant therapy for pancreatic cancer; not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-01-19Clinical Trial Update: Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC [Phase 2]
A Phase II study evaluating concurrent radiotherapy with envafolimab and capecitabine in locally advanced pancreatic cancer is in progress, …
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Ultrasound Monitoring of Abdominal Soft Tissue [NA]
Clinical trial update for ultrasound monitoring in pancreatic and liver cancers; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia [Phase 1]
Phase 1 study comparing repeated doses of an investigational drug versus placebo to assess effects on appetite in advanced cancer and anorex…
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas [Phase 2]
Phase 2 clinical trial exploring chemotherapy and surgical resection for pancreatic adenocarcinoma with hepatic oligometastases.
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating SHR-1701 in combination with gemcitabine and albumin-bound paclitaxel in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma [Phase 3]
A randomized Phase III trial comparing Folfirinox to Gemcitabine in locally advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-08Clinical Trial Update: A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer [Phase 1, Phase 2]
This completed Phase 1/2 study evaluated a five-drug regimen (gemcitabine, nab-paclitaxel, capecitabine, cisplatin, and irinotecan) in metas…